Investing.com - Renalytix AI Nas reported on Wednesday first quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Renalytix AI Nas announced earnings per share of $-0.32 on revenue of $969K. Analysts polled by Investing.com anticipated EPS of $-0.16 on revenue of $1.1M.
Renalytix AI Nas shares are down 88% from the beginning of the year and are trading at $1.88 , down-from-52-week-high.
Renalytix AI Nas follows other major Healthcare sector earnings this month
Renalytix AI Nas's report follows an earnings beat by Eli Lilly on November 1, who reported EPS of $1.98 on revenue of $6.94B, compared to forecasts EPS of $1.91 on revenue of $6.91B.
Novo Nordisk ADR had beat expectations on November 2 with third quarter EPS of $0.8409 on revenue of $6.04B, compared to forecast for EPS of $0.837 on revenue of $6.04B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar